Frazier Life Sciences Management L.P. Has $28.31 Million Holdings in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT)

Frazier Life Sciences Management L.P. grew its holdings in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 0.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,764,232 shares of the company’s stock after buying an additional 80,000 shares during […]

Related Keywords

Larry Todd Edwards ,Cantor Fitzgerald ,Arcutis Biotherapeutics ,Patrick Burnett ,Capital Management ,Ghisallo Capital Management ,Needham Company ,Nasdaq ,Arcutis Biotherapeutics Inc ,Securities Exchange Commission ,Goldman Sachs Group ,Venture Partners Investment Advisor ,Frazier Life Sciences Management ,Free Report ,Get Free Report ,Exchange Commission ,Todd Edwards ,Visit Holdingschannel ,